Harvard Bioscience (HBIO) EBT (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly EBT of -$3.3 million for Q1 2026, up 93.49% year-over-year from -$1.7 million in Q1 2025, and down 3.21% quarter-over-quarter from -$3.2 million in Q4 2025.
Harvard Bioscience (HBIO) EBT (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported EBT for 17 consecutive years, with -$3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT rose 93.49% year-over-year to -$3.3 million; the TTM figure through Mar 2026 stood at -$9.9 million (up 82.93% YoY), while the FY2025 annual figure was -$57.4 million, down 391.95% from the prior year.
- EBT declined to -$3.3 million in Q1 2026 per HBIO's latest filing, from -$3.2 million in the prior quarter.
- Across five years, EBT topped out at $3.4 million in Q2 2022 and bottomed at -$50.8 million in Q1 2025.
- Historically, EBT has averaged -$4.9 million across 5 years, with a median of -$2.3 million in 2025.
- On a YoY basis, EBT climbed as much as 641.3% in 2022 and fell as far as 10522.22% in 2022.
- Harvard Bioscience's EBT stood at -$892000.0 in 2022, then decreased by 23.65% to -$1.1 million in 2023, then surged by 153.49% to $590000.0 in 2024, then tumbled by 643.05% to -$3.2 million in 2025, then fell by 3.21% to -$3.3 million in 2026.
- Business Quant data shows HBIO's EBT at -$3.3 million in Q1 2026, -$3.2 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.05 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 554.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | -46.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 474.16 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 235.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 180.10 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 108.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -48.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 158.00 Mn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | -2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.90 Mn |
| Mar 31, 2026 | -3.31 Mn |
| Dec 31, 2025 | -3.20 Mn |
| Sep 30, 2025 | -1.13 Mn |
| Jun 30, 2025 | -2.25 Mn |
| Mar 31, 2025 | -50.79 Mn |
| Dec 31, 2024 | 590,000.00 |
| Sep 30, 2024 | -4.49 Mn |
| Jun 30, 2024 | -3.28 Mn |
| Mar 31, 2024 | -4.48 Mn |
| Dec 31, 2023 | -1.10 Mn |
| Sep 30, 2023 | -562,000.00 |
| Jun 30, 2023 | -2.10 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | -892,000.00 |
| Sep 30, 2022 | -4.69 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Mar 31, 2022 | -7.02 Mn |
| Dec 31, 2021 | 1.13 Mn |
| Sep 30, 2021 | 45,000.00 |